State of Wisconsin Investment Board
ZNTL icon

State of Wisconsin Investment Board’s Zentalis Pharmaceuticals ZNTL Stock Holding History

State of Wisconsin Investment Board’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-32,052
Closed -$131K – 2375
2024
Q2 		$131K Sell
32,052
-906
-3% -$10.1K ﹤0.01% 2204
2024
Q1 		$519K Sell
32,958
-4,251
-11% -$58.5K ﹤0.01% 1738
2023
Q4 		$564K Sell
37,209
-6,251
-14% -$91.2K ﹤0.01% 1658
2023
Q3 		$872K Sell
43,460
-22,748
-34% -$577K ﹤0.01% 1447
2023
Q2 		$1.87M Sell
66,208
-13,755
-17% -$330K 0.01% 1309
2023
Q1 		$1.38M Buy
79,963
+1,978
+3% +$40.1K ﹤0.01% 1397
2022
Q4 		$1.57M Buy
77,985
+31,999
+70% +$688K 0.01% 1376
2022
Q3 		$996K Sell
45,986
-3,085
-6% -$84.4K ﹤0.01% 1546
2022
Q2 		$1.38M Buy
49,071
+1,071
+2% +$28.4K ﹤0.01% 1482
2022
Q1 		$2.21M Sell
48,000
-4,600
-9% -$248K ﹤0.01% 1467
2021
Q4 		$4.42M Buy
52,600
+8,800
+20% +$681K 0.01% 1080
2021
Q3 		$2.92M Buy
43,800
+5,100
+13% +$294K 0.01% 1198
2021
Q2 		$2.06M Hold
38,700
– – ﹤0.01% 1283
2021
Q1 		$1.68M Sell
38,700
-1,300
-3% -$56K ﹤0.01% 1267
2020
Q4 		$2.08M Buy
40,000
+23,500
+142% +$1.06M ﹤0.01% 1193
2020
Q3 		$539K Hold
16,500
– – ﹤0.01% 1462
2020
Q2 		$792K Buy
+16,500
New +$633K ﹤0.01% 1289

Other funds holding ZNTL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State of Wisconsin Investment Board's ZNTL Position: Q3 2024 in Review

State of Wisconsin Investment Board sold out of Zentalis Pharmaceuticals (ZNTL) in Q3 2024, closing a stake of 32,052 shares — an estimated $131K sold.

State of Wisconsin Investment Board first reported a position in ZNTL in Q2 2020 and held it in 17 quarters. The position peaked at $4.42M in Q4 2021. 136 funds tracked by Wall St. Rank hold ZNTL as of Q3 2024.

  • State of Wisconsin Investment Board reported no remaining Zentalis Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 32,052 Zentalis Pharmaceuticals shares in Q3 2024, an estimated $131K.
  • State of Wisconsin Investment Board first reported a position in Zentalis Pharmaceuticals in Q2 2020 and held it in 17 quarters.
  • State of Wisconsin Investment Board's Zentalis Pharmaceuticals position peaked at $4.42M in Q4 2021.
  • 136 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2024, filed 14 Nov 2024.